Testing effectiveness (Phase 2)Active Not RecruitingNCT07213583
What this trial is testing
Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM
Who this might be right for
Amyloid Transthyretin Cardiomyopathy
Neurimmune AG 35
Showing 20 of 0 results